857 related articles for article (PubMed ID: 27153853)
41. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
Liu F; Zhang H; Song H
Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
[TBL] [Abstract][Full Text] [Related]
42. The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis.
Oh TG; Wang SM; Acharya BR; Goode JM; Graham JD; Clarke CL; Yap AS; Muscat GEO
EBioMedicine; 2016 Apr; 6():59-72. PubMed ID: 27211549
[TBL] [Abstract][Full Text] [Related]
43. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
44. The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion.
Neth P; Ries C; Karow M; Egea V; Ilmer M; Jochum M
Stem Cell Rev; 2007 Jan; 3(1):18-29. PubMed ID: 17873378
[TBL] [Abstract][Full Text] [Related]
45. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
46. Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits migration and invasion through Epithelial-Mesenchymal-Transition in lung cancer.
Hao Y; Yang X; Zhang D; Luo J; Chen R
Gene; 2017 Apr; 608():1-12. PubMed ID: 28119085
[TBL] [Abstract][Full Text] [Related]
47. Salinomycin suppresses TGF-β1-induced epithelial-to-mesenchymal transition in MCF-7 human breast cancer cells.
Zhang C; Lu Y; Li Q; Mao J; Hou Z; Yu X; Fan S; Li J; Gao T; Yan B; Wang B; Song B; Li L
Chem Biol Interact; 2016 Mar; 248():74-81. PubMed ID: 26896736
[TBL] [Abstract][Full Text] [Related]
48. Role of miR-155 in drug resistance of breast cancer.
Yu DD; Lv MM; Chen WX; Zhong SL; Zhang XH; Chen L; Ma TF; Tang JH; Zhao JH
Tumour Biol; 2015 Mar; 36(3):1395-401. PubMed ID: 25744731
[TBL] [Abstract][Full Text] [Related]
49. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
50. Antrodin C inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via suppression of Smad2/3 and β-catenin signaling pathways.
Kumar KJ; Vani MG; Chueh PJ; Mau JL; Wang SY
PLoS One; 2015; 10(2):e0117111. PubMed ID: 25658913
[TBL] [Abstract][Full Text] [Related]
51. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
53. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
54. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway.
Liu X; Chen L; Fan Y; Hong Y; Yang X; Li Y; Lu J; Lv J; Pan X; Qu F; Cui X; Gao Y; Xu D
Cell Death Dis; 2019 Jul; 10(7):517. PubMed ID: 31273201
[TBL] [Abstract][Full Text] [Related]
55. MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells.
Ho CS; Yap SH; Phuah NH; In LL; Hasima N
Lung Cancer; 2014 Feb; 83(2):154-62. PubMed ID: 24360396
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
57. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Nam SJ; Lee JE
Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
[TBL] [Abstract][Full Text] [Related]
58. High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF-β-dependent epithelial-mesenchymal transition in breast cancer.
Zhang C; Han Y; Huang H; Qu L; Shou C
Breast Cancer Res Treat; 2014 Sep; 147(2):265-81. PubMed ID: 25129343
[TBL] [Abstract][Full Text] [Related]
59. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
Sengupta S; Jana S; Bhattacharyya A
Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
[TBL] [Abstract][Full Text] [Related]
60. Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.
Santibanez JF; Obradović H; Kukolj T; Krstić J
Dev Dyn; 2018 Mar; 247(3):382-395. PubMed ID: 28722327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
